3-53186199-G-A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_006254.4(PRKCD):​c.1119G>A​(p.Glu373Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.272 in 1,613,704 control chromosomes in the GnomAD database, including 60,470 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.29 ( 6478 hom., cov: 32)
Exomes 𝑓: 0.27 ( 53992 hom. )

Consequence

PRKCD
NM_006254.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 1.23

Publications

21 publications found
Variant links:
Genes affected
PRKCD (HGNC:9399): (protein kinase C delta) The protein encoded by this gene is a member of the protein kinase C family of serine- and threonine-specific protein kinases. The encoded protein is activated by diacylglycerol and is both a tumor suppressor and a positive regulator of cell cycle progression. Also, this protein can positively or negatively regulate apoptosis. Defects in this gene are a cause of autoimmune lymphoproliferative syndrome. [provided by RefSeq, Aug 2017]
PRKCD Gene-Disease associations (from GenCC):
  • autoimmune lymphoproliferative syndrome, type III caused by mutation in PRKCD
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • autoimmune lymphoproliferative syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal systemic lupus erythematosus type 16
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • common variable immunodeficiency
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 3-53186199-G-A is Benign according to our data. Variant chr3-53186199-G-A is described in ClinVar as [Benign]. Clinvar id is 403345.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.23 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.321 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PRKCDNM_006254.4 linkc.1119G>A p.Glu373Glu synonymous_variant Exon 13 of 19 ENST00000330452.8 NP_006245.2 Q05655-1A0A024R328

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PRKCDENST00000330452.8 linkc.1119G>A p.Glu373Glu synonymous_variant Exon 13 of 19 1 NM_006254.4 ENSP00000331602.3 Q05655-1

Frequencies

GnomAD3 genomes
AF:
0.289
AC:
43862
AN:
151990
Hom.:
6470
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.326
Gnomad AMI
AF:
0.238
Gnomad AMR
AF:
0.293
Gnomad ASJ
AF:
0.264
Gnomad EAS
AF:
0.209
Gnomad SAS
AF:
0.256
Gnomad FIN
AF:
0.282
Gnomad MID
AF:
0.307
Gnomad NFE
AF:
0.276
Gnomad OTH
AF:
0.298
GnomAD2 exomes
AF:
0.271
AC:
67887
AN:
250708
AF XY:
0.271
show subpopulations
Gnomad AFR exome
AF:
0.328
Gnomad AMR exome
AF:
0.258
Gnomad ASJ exome
AF:
0.249
Gnomad EAS exome
AF:
0.205
Gnomad FIN exome
AF:
0.282
Gnomad NFE exome
AF:
0.280
Gnomad OTH exome
AF:
0.278
GnomAD4 exome
AF:
0.270
AC:
394688
AN:
1461596
Hom.:
53992
Cov.:
39
AF XY:
0.271
AC XY:
196889
AN XY:
727092
show subpopulations
African (AFR)
AF:
0.329
AC:
11023
AN:
33476
American (AMR)
AF:
0.266
AC:
11861
AN:
44634
Ashkenazi Jewish (ASJ)
AF:
0.252
AC:
6590
AN:
26136
East Asian (EAS)
AF:
0.163
AC:
6481
AN:
39694
South Asian (SAS)
AF:
0.254
AC:
21929
AN:
86252
European-Finnish (FIN)
AF:
0.282
AC:
15067
AN:
53404
Middle Eastern (MID)
AF:
0.319
AC:
1839
AN:
5768
European-Non Finnish (NFE)
AF:
0.273
AC:
303481
AN:
1111844
Other (OTH)
AF:
0.272
AC:
16417
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
17643
35286
52929
70572
88215
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10090
20180
30270
40360
50450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.289
AC:
43906
AN:
152108
Hom.:
6478
Cov.:
32
AF XY:
0.287
AC XY:
21371
AN XY:
74344
show subpopulations
African (AFR)
AF:
0.326
AC:
13515
AN:
41476
American (AMR)
AF:
0.292
AC:
4471
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.264
AC:
917
AN:
3470
East Asian (EAS)
AF:
0.209
AC:
1081
AN:
5172
South Asian (SAS)
AF:
0.256
AC:
1235
AN:
4828
European-Finnish (FIN)
AF:
0.282
AC:
2986
AN:
10590
Middle Eastern (MID)
AF:
0.320
AC:
94
AN:
294
European-Non Finnish (NFE)
AF:
0.276
AC:
18765
AN:
67970
Other (OTH)
AF:
0.296
AC:
625
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1603
3206
4809
6412
8015
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
442
884
1326
1768
2210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.278
Hom.:
6048
Bravo
AF:
0.290
Asia WGS
AF:
0.229
AC:
796
AN:
3478
EpiCase
AF:
0.288
EpiControl
AF:
0.290

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Nov 12, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 47% of patients studied by a panel of primary immunodeficiencies. Number of patients: 45. Only high quality variants are reported. -

Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Autoimmune lymphoproliferative syndrome, type III caused by mutation in PRKCD Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 25, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
4.4
DANN
Benign
0.54
PhyloP100
1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2230494; hg19: chr3-53220215; COSMIC: COSV57846818; COSMIC: COSV57846818; API